French Version of the Banff Patellar Instability Instrument 2.0
French Translation and Validation of the Banff Patellar Instability Instrument 2.0
1 other identifier
observational
52
1 country
1
Brief Summary
There are several treatment options for patellofemoral instability, but no established guidelines currently exist. An important step toward developing a consensus is to examine the influence of each intervention through the collection of both subjective and objective outcomes. Most outcome measures commonly used for knee pathologies are primarily designed to monitor degenerative conditions (e.g., osteoarthritis) or ligamentous instability (e.g., anterior cruciate ligament rupture). Very few questionnaires are specific to patellar instability, a condition characterized by distinct signs and symptoms compared to other knee disorders. The Banff Patellar Instability Instrument (BPII) was developed with this gap in mind, in accordance with the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) criteria. This condition-specific tool is designed to subjectively assess the functional impact of patellofemoral instability on patients' quality of life, which is the most important factor in evaluating treatment success. Currently, there is no validated French-language outcome measure specific to patellofemoral instability. To improve patient care, the availability of such a validated tool in French is essential, both for clinical use and for conducting future research. To address this issue, the primary objective of this study is to translate the Banff Patellar Instability Instrument 2.0 (BPII 2.0) into French, following the three-step process described in the IQOLA project and in accordance with the guidelines outlined by the American Academy of Orthopaedic Surgeons (AAOS), and to evaluate its validity in a French-speaking population. Research Question Is the French version of the BPII 2.0 a valid tool to assess function in French-speaking patients diagnosed with patellofemoral instability? Specific Objectives To translate the Banff Patellar Instability Instrument 2.0 into French using a dual forward-backward translation process. To evaluate the psychometric properties of the French version of the BPII 2.0, including its reliability and validity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 15, 2021
CompletedFirst Submitted
Initial submission to the registry
April 10, 2025
CompletedFirst Posted
Study publicly available on registry
April 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedApril 17, 2025
April 1, 2025
3.7 years
April 10, 2025
April 10, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Questionnaire Banff Patellar Instability 2.0 Index in French
Questionnaire. (0-100 (0 = Worst, 100 = Best))
Baseline, 1 week and 6 month post intervention
Questionnaire Anterior Knee Pain Scale (Kujala)
Questionnaire. (0-100 (0 = Worst, 100 = Best))
Baseline and 6 month post intervention
Socio-Demographic
Age, Sex, Time since symptoms, Scolarship, Nationality
Baseline
Study Arms (1)
validation
person with patellar instability that will respond to the questionnaires
Eligibility Criteria
Patients consulting at the CHUS in Sherbrooke or at the Schriners Hospital in Montreal for patellar instability
You may qualify if:
- patient diagnosed with patellar instability with conservative or surgical treatment
- fluent in both spoken and written French
You may not qualify if:
- Patients who are unable to understand and/or respond to the questionnaire
- Patients with another diagnosis or knee pathology under study (e.g., complex ligament tear of the knee, gonarthrosis)
- Patients with another diagnosis or lower limb pathology under study with secondary functional impairment (e.g., coxarthrosis)
- Patients answering fewer than 19 questions (out of 23 questions)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CIUSSS de l'Estrie-CHUS, 3001, 12e Ave Nord
Sherbrooke, Quebec, J1H5N4, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
François Vézina, Doctor
Université de Sherbrooke
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- orthopaedic surgeon
Study Record Dates
First Submitted
April 10, 2025
First Posted
April 17, 2025
Study Start
November 15, 2021
Primary Completion
August 1, 2025
Study Completion
August 1, 2025
Last Updated
April 17, 2025
Record last verified: 2025-04